Table 1.
Characteristic | Value |
---|---|
Gender | |
Male | 3 (33.3) |
Female | 6 (66.7) |
Median age at resection (IQR) (y) | 33.8 (20) |
Median disease duration at resection (IQR) (y) | 10.5 (8) |
Previous surgery | |
Yes | 4 (44.4) |
No | 5 (55.6) |
Smoking | |
Current | 1 (11.1) |
Previous | 4 (44.4) |
Never | 4 (44.4) |
Disease location | |
Ileal | 5 (55.6) |
Colonic | 0 (0.0) |
Ileocolonic | 4 (44.4) |
Upper GI | 0 (0.0) |
Disease behaviour | |
Inflammatory | 0 (0.0) |
Stricturing | 9 (100.0) |
Fistulating | 0 (0.0) |
Oral 5ASA Treatmenta | |
Yes | 3 (33.3) |
No | 6 (66.7) |
Oral steroid treatmenta | |
Yes | 6 (66.7) |
No | 3 (33.3) |
Thiopurine treatmenta | |
Yes | 2 (22.2) |
No | 7 (77.8) |
Methotrexate treatmenta | |
Yes | 1 (11.1) |
No | 8 (88.9) |
Infliximab treatmenta | |
Yes | 1 (11.1) |
No | 8 (88.9) |
Adalimumab treatmenta | |
Yes | 1 (11.1) |
No | 8 (88.9) |
Mean Hb (SD) (g/L) | 129.0 (18.8) |
Mean WCC (SD) (×109/L) | 8.2 (3.7) |
Mean CRP (SD) (mg/L) | 15.6 (11.8) |
Mean albumin (SD) (g/L) | 38.8 (9.5) |
Unless otherwise stated values represent total numbers, with values in parentheses representing percentage.
IQR, interquartile range; SD, standard deviation; g, grams; mg, milligrams; L, litre.
Treatment was either current or within the previous 3 mo of surgery.